Library Category: White Papers

A retrospective, non-experimental, non-interventional study was conducted at 3 health care organizations to identify clinical gaps in care for patients with stage 3 or 4 chronic kidney disease (CKD), and financial opportunity from risk adjustment payment systems. Lack of evaluation for CKD in patients with diabetes was also assessed. Methods: Outpatient longitudinal laboratory results and patient…

Anemia is a disease with high prevalence, high cost of care, and low quality of life.  Through the engagement of clinical laboratories and diagnostic workflows, health systems can help improve the testing strategies, diagnosis, and patient outcomes for anemia. Clinical Lab 2.0, as shown in the model below3, highlights how the use of longitudinal laboratory…

Chronic kidney disease (CKD) affects an estimated one in seven American adults, with about 37 million individuals having some level of CKD and is the ninth leading cause of death. Over 40% of patients with severe renal impairment are unaware that their kidneys are impaired. According to the CDC, $81.6 billion was spent on treating…

The COVID-19 pandemic has illustrated how today’s health care environment and current delivery models are ill-equipped to adequately address community health and public safety. This Project Santa Fe Foundation thought leadership publication proposes an advanced role for the clinical laboratory as a key partner for population health management, health outcomes, and public safety.